Cite
Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus.
MLA
Vital, Edward M., et al. “Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus.” Arthritis & Rheumatology, vol. 67, no. 6, June 2015, pp. 1586–91. EBSCOhost, https://doi.org/10.1002/art.39085.
APA
Vital, E. M., Wittmann, M., Edward, S., Md Yusof, M. Y., MacIver, H., Pease, C. T., Goodfield, M., & Emery, P. (2015). Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus. Arthritis & Rheumatology, 67(6), 1586–1591. https://doi.org/10.1002/art.39085
Chicago
Vital, Edward M., Miriam Wittmann, Sara Edward, Md Yuzaiful Md Yusof, Helen MacIver, Colin T. Pease, M. Goodfield, and Paul Emery. 2015. “Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus.” Arthritis & Rheumatology 67 (6): 1586–91. doi:10.1002/art.39085.